Related Experiment Video

Updated: Aug 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiac enzymes, renal failure and renal transplantation

Huseyin Bozbas1, Aylin Yildirir, Haldun Muderrisoglu

  • 1Department of Cardiology, Baskent University Hospital, F. Cakmak Cad. 10.sok, Bahcelievler 06490 Ankara, Turkey. mdhbozbas@yahoo.com

Clinical Medicine & Research
|April 6, 2006
PubMed

Insights

Cardiac troponin I is recommended for diagnosing heart injury in kidney transplant patients, as its levels remain stable. Cardiac troponin T may be elevated, potentially affecting accuracy in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker analysis

Background:

  • Serum markers for cardiac injury (myoglobin, CK-MB) are less reliable in renal failure.
  • Cardiac troponins (CTnI, CTnT) show reduced accuracy in patients on renal replacement therapy.
  • Limited data exist on cardiac biomarker levels post-kidney transplantation.

Purpose of the Study:

  • To evaluate the diagnostic utility of cardiac troponins in kidney transplant recipients.
  • To determine if cardiac troponin levels are altered after renal transplantation.
  • To identify the preferred biomarker for myocardial injury in this patient group.

Main Methods:

  • Review of current literature on cardiac biomarkers in renal transplant patients.
  • Analysis of studies reporting serum levels of cardiac troponin I and T.
  • Comparison of diagnostic accuracy in patients with and without renal impairment.

Main Results:

  • Cardiac troponin I levels appear unaltered in patients post-renal transplantation.
  • Cardiac troponin T levels may be elevated in kidney transplant recipients.
  • Altered levels of traditional cardiac markers are noted in renal failure.

Conclusions:

  • Cardiac troponin I is suggested as the preferred biomarker for diagnosing myocardial injury in kidney transplant patients.
  • Further clinical trials are necessary to confirm the reliability of cardiac troponins in this population.
  • Careful interpretation of cardiac troponin T is advised in kidney transplant recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...